IMARC Group has recently released a new research study titled “South Korea Catheters Market Size, Share, Trends and Forecast by Product Type, End User, and Region, 2025-2033”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.

South Korea Catheters Market Overview

The South Korea Catheters Market size reached USD 453.59 Million in 2024 and is projected to reach USD 823.44 Million by 2033, growing at a CAGR of 6.85% during 2025-2033. Growth is driven by rising demand for minimally invasive interventions, advanced technology, and a focus on improved healthcare delivery. Product segments like urinary, cardiovascular, and specialty catheters are expanding with strong support from healthcare professionals, hospitals, and clinics.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

South Korea Catheters Market Key Takeaways

• The market size in 2024 was USD 453.59 Million.
• The market is expected to grow at a CAGR of 6.85% during 2025-2033.
• The forecast period covers 2025 to 2033.
• Balloon catheter usage has expanded notably in interventional cardiology due to advanced designs and improved clinical protocols.
• Innovations such as a photodynamic therapy catheter for oesophageal cancer were developed in 2024, enhancing targeted treatment and patient comfort.
• Hospitals are increasingly adopting safety-engineered catheters with integrated needle guards and antimicrobial hubs, reducing complications and improving clinical safety.
• The largest end-users consist of hospitals, diagnostic facilities, and specialty clinics.

Sample Request Link: https://www.imarcgroup.com/south-korea-catheters-market/requestsample

Market Growth Factors

Growing usage of balloon catheters in South Korea drives market expansion, particularly percutaneous transluminal coronary angioplasty (PTCA) balloon catheters. This growth reflects evolving interventional cardiology practices where enhanced catheter designs, offering improved flexibility and controlled inflation, support safer and more precise minimally invasive heart procedures. Hospitals are investing in training and upgraded catheterization workflows to promote patient recovery and reduced hospital stays.

Innovative catheter designs for cancer treatment also stimulate market growth. In April 2024, South Korean scientists developed a novel photodynamic therapy catheter integrating a light-emitting unit and an inbuilt stent for oesophageal cancer. This catheter allows targeted therapy with structural support, minimizing trauma and reducing the need for frequent endoscopies. Hospitals and cancer centers are adopting these next-generation devices, especially for patients unfit for surgery.

Safety-engineered catheters with integrated needle guards and antimicrobial hubs have been increasingly procured by South Korean hospitals. Reports from 2024 indicate notable reductions in device-related complications and infections. Hospitals incorporate these devices into standard protocols with focused staff training, increasing procedural efficiency and regulatory compliance. This trend enhances patient and clinician safety, boosting market preference for safety-focused catheter solutions.

Market Segmentation

Product Type Insights:

• Cardiovascular Catheters: Catheters used in heart-related medical procedures, reflecting high demand due to cardiovascular diseases.
• Urology Catheters: Devices catering to urinary tract applications, supporting a significant product segment.
• Intravenous Catheters: Used for intravenous therapies and fluid delivery.
• Neurovascular Catheters: Specialized catheters for neurological and vascular interventions.
• Specialty Catheters: Include catheters designed for specific medical conditions and treatments, such as cancer therapy.
• Others: Additional catheter types not classified under the above categories.

End User Insights:

• Hospitals and Clinics: Primary users, representing the largest market segment for catheters.
• Ambulatory Surgical Centers: Facilities performing same-day surgical procedures using catheters.
• Others: Other end users including diagnostic facilities and specialty clinics.

Regional Insights

The Seoul Capital Area is identified as a major regional market within South Korea. The report details robust demand driven by metropolitan healthcare infrastructure and a concentration of hospitals and specialty clinics. Other notable regions include Yeongnam (Southeastern Region), Honam (Southwestern Region), and Hoseo (Central Region). Specific market share or CAGR by region is not provided.

Recent Developments & News

In June 2024, Seoul-based DeepQure obtained FDA approval for an Investigational Device Exemption to launch an early feasibility study in the U.S. for its HyperQure extravascular renal denervation system. This energy-based laparoscopic device targets sympathetic nerves around the renal artery without harming the vessel lining. The first in-human study is ongoing in Korea, with plans for global expansion, marking South Korea’s advancing position in medical device innovation.

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302